T1 Protein 1174 1178 IFNα
T2 Gene 779 808 RNA-LPX triggers interferon-α
T3 Level 1631 1633 DC
T5 Protein 1509 1534 polypeptide-based antigen
T6 Biomarker 414 417 RNA
T7 Gene 1029 1036 RNA-LPX
T8 Biomarker 779 782 RNA
T9 Level 52 56 APCs
T10 Level 875 877 DC
T11 Gene 779 786 RNA-LPX
T12 CL 714 728 DC populations
T13 Level 1117 1143 effector and memory T-cell
T14 Intervention 326 330  DCs
T15 Protein 810 814 IFNα
T16 Level 26 50 antigen presenting cells
T17 Gene 1263 1270 RNA-LPX
T19 Intervention 1174 1188 IFNα-dependent
T20 Intervention 733 744 macrophages
T21 Intervention 387 400 intravenously
T22 Protein 756 777 lymphoid compartments
T23 Biomarker 1267 1270 LPX
T24 Level 259 262 DCs
T25 Condition 1202 1221 progressive tumours
T26 Biomarker 589 592 LPX
T27 Organism 1337 1354 melanoma patients
T28 Biomarker 1029 1032 RNA
T29 Level 327 329 DC
T30 Intervention 848 859 macrophages
T31 Biomarker 414 428 RNA-lipoplexes
T32 Protein 1384 1388 IFNα
T33 Condition 1762 1768 cancer
T34 Level 840 842 DC
T35 Intervention 611 624 extracellular
T36 Protein 459 464 lipid
T37 Gene 430 437 RNA-LPX
T38 Condition 1283 1296 shared tumour
T39 Gene 1561 1568 RNA-LPX
T40 Biomarker 1553 1556 RNA
T41 Intervention 839 843  DCs
T42 Level 259 261 DC
T43 Gene 1029 1102 RNA-LPX encoding viral or mutant neo-antigens or endogenous self-antigens
T46 Protein 566 575 molecular
T47 Biomarker 1561 1564 RNA
T48 Intervention 1400 1423 antigen-specific T-cell
T49 Biomarker 602 605 RNA
T51 Level 714 716 DC
T54 Biomarker 1263 1266 RNA
T55 Level 167 184 T-cell responses1
T56 Level 84 91 T cells
T57 Level 242 258 dendritic cells 
T58 Biomarker 430 433 RNA
